http://www.fibrogen.com
FibroGen, Inc. Company Intro
FibroGen creates first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.
Industry
Healthcare
FibroGen, Inc. Headquaters
409 Illinois Street
San Francisco,94158
United States
FibroGen, Inc. Share price
18 Jun 2021 01:40 GMT
$25.30
-0.54 (-2.09 %)
FibroGen, Inc. Market cap
$2.42 B
WMC RANKING
2021
FibroGen, Inc. # 52
BiotechnologyLatest FibroGen, Inc. News
14 Jun 2021
Duchenne Muscular Dystrophy Drugs Market Overview, Size ...
... findings will be helpful for anyone who needs some guidance or direction when making important decisions related to their company's future growth strategy.
14 Jun 2021
Global Connective Tissue Growth Factor Sales Market ...
Additional companies can be included in the report as per request. BLR Bio LLC FibroGen Inc ProMetic Life Sciences Inc RXi Pharmaceuticals Corp. On the basis ...
14 Jun 2021
Ammonia (NH3) Gas Detection Market 2021-2026 : Regional ...
... in Ammonia (NH3) Gas Detection Industry | Top Companies: Calibration Technologies, Industrial Scientific, Teledyne, Draeger, RAE Systems, Bacharach, Inc., ...
WMC Market Score
WMC Market to Revenue Score
FibroGen, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| FibroGen, Inc. | USD | $119,294 | $346,454 | $-228,780 | $24,200B | 52 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $570,970B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $487,600B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $397,770B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $182,780B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total FibroGen, Inc. Social Followers vs Top 4 Industry Competitors
FibroGen, Inc. Post vs Top 4 Industry Competitors
FibroGen, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
FibroGen, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
FibroGen, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| FibroGen, Inc. | 1.29 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 24.00 | 16.21 | 100 | 0 | 0 | 53.90 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.01 | 8.79 | 86 | 0 | 0 | 49.84 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.93 | 0.02 | 2 | 0 | 0 | 2.84 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
